wall street stock market

Tesla’s stock was up $20 to an all-time high of $298.52 on Monday which gave the company a market cap of $48.7 billion and the shares are up another $5 today to break $300. This pushed Tesla’s market cap higher than Ford’s $45.5 billion and is closing in on GM’s $51.2 billion.

There were what I’d call two and a half reasons for Tesla’s stock price to pop on Monday. The top two were a short squeeze and a bullish note from Morgan Stanley and the half reason was the company reporting its March quarter deliveries and production which were a bit better than expected.

Tesla Motors unveils the new lower-priced Model 3 sedan at the Tesla Motors design studio in Hawthorne, Calif. (AP Photo/Justin Pritchard)

Shorts are taking it in the shorts

wall street stock market: Maxwell Technologies, Inc.(MXWL)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Maxwell Technologies Inc. (NASDAQ: MXWL) were down 15 percent to $5.34. Maxwell reported amended terms for deal with Viex Capital and announced a proposed offering of $50 million convertible senior notes due 2022.

  • [By Monica Gerson]

    Maxwell Technologies (NASDAQ: MXWL) surged 9.20% to $10.21. The volume of Maxwell Technologies shares traded was 325% higher than normal. Maxwell’s trailing-twelve-month revenue is $190.57 million.

  • [By Jim Robertson]

    On Tuesday, our Under the Radar Moversnewsletter suggestedgoing long on small cap energy storage and power delivery stock Maxwell Technologies (NASDAQ: MXWL):

wall street stock market: Portola Pharmaceuticals, Inc.(PTLA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Portola Pharmaceuticals Inc (NASDAQ: PTLA) shares dropped 23 percent to $21.92 after announcing Phase III Betrixaban results.

    Shares of Spark Energy Inc (NASDAQ: SPKE) were down 16 percent to $20.43. Spark Energy reported Q4 GAAP EPS of $(0.01) and adjusted EBITDA of $16.3 million.

  • [By Lisa Levin]

    Portola Pharmaceuticals Inc (NASDAQ: PTLA) shares dropped 30 percent to $20.08 after announcing Phase III Betrixaban results.

    Shares of Spark Energy Inc (NASDAQ: SPKE) were down 14 percent to $20.96. Spark Energy reported Q4 GAAP EPS of $(0.01) and adjusted EBITDA of $16.3 million.

  • [By Todd Campbell]

    Portola Pharmaceuticals’ (NASDAQ:PTLA)could have two commercial-stage drugs on the market next year, but turning them into top-sellers will require a lot of money. Is Portola Pharmaceuticals’ balance sheet flush enough with cash to get its drugs across the finish line?

wall street stock market: Sagent Pharmaceuticals Inc.(SGNT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Sagent Pharmaceuticals Inc (NASDAQ: SGNT) got a boost, shooting up 40 percent to $21.65 as the company agreed to be acquired by Nichi-Iko Pharmaceutical for $21.75 per share. RBC Capital downgraded Sagent Pharmaceuticals from Outperform to Sector Perform.

wall street stock market: Envision Healthcare Holdings, Inc.(EVHC)

Advisors’ Opinion:

  • [By Lisa Levin]

    Envision Healthcare Holdings Inc (NYSE: EVHC) shares shot up 211 percent to $70.15. Envision Healthcare and Amsurg Corp (NASDAQ: AMSG) reported the completion of their merger.

  • [By Paul Ausick]

    Envision Healthcare Corp. (NYSE: EVHC) dropped about 9.3% Tuesday to post a new 52-week low of $43.22 after closing Monday at $47.67. The 52-week high is $74.75. Volume of around 10 million shares traded was about six times the daily average. The company had no specific news.

  • [By Ben Levisohn]

    Even on a day like today, somebody had to be the worst performer in the S&P 500, and today that somebody is Envision Healthcare (EVHC), which missed earnings forecasts last night.

wall street stock market: Constellation Brands Inc(STZ)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Constellation Brands (STZ) has rallied 4.7% to $169 after beating earnings forecasts and offering optimistic guidance.

    Greenbrier Cos. (GBX) has advanced 2.1% to $48.25 after getting upgraded to Buy from Neutral at BofA Merrill Lynch.

  • [By WWW.THESTREET.COM]

    Then on Thursday, Constellation Brands (STZ) reports, and as we learned yesterday, this is Cramer’s favorite liquor stock. Also on Thursday, earnings from Nike (NKE) , a battleground Cramer said he’s steering clear of, and Micron Technology (MU) , which will likely fall no matter how good its quarter.

  • [By Rich Duprey]

    It’s not all bad news, as brewers such as Lagunitas and Dogfish Head, among others, were up by double-digit percentages. Constellation Brands (NYSE:STZ) also surged, and though much of that increase might be attributable to its imported Corona brands, it also has its Ballast Point craft brand to thank, as it’s been living up to its reputation as the fastest-growing craft beer.

  • [By ]

    Earlier this quarter, I told you how alcohol distributor Constellation Brands Inc. (NYSE:STZ) acquired a 10% stake in Canadian medical marijuana firm Canopy Growth Corp. (TSE:WEED). A major alcohol distributor buying a marijuana company would have been unfathomable just a few years ago. But with legalization gaining steam nationwide, this deal is shaping up to be one of many to come in the industry.

  • [By WWW.THESTREET.COM]

    Is it time to crown a new king of beers? After speaking with Constellation Brands (STZ) CEO on Thursday night’s show, Cramer said it was time to take a fresh look at the beer sector to see if a reshuffling is in order.

  • [By Craig Jones]

    Najarian also noticed big upside call options buying in Constellation Brands, Inc. (NYSE: STZ). Around 5,000 contracts of the January 240 calls were traded and he decided to follow the trade. He added that he also likes Wal-Mart Stores Inc (NYSE: WMT) for upside calls buying.

wall street stock market: Cott Corporation(COT)

Advisors’ Opinion:

  • [By Dan Moskowitz]

    Cott (NYSE: COT  ) produces and sells over 200 different types of beverages in over 50 countries, and it implements a highly effective strategy. Cott is what is known as a Fast Follower, which makes it unique to other beverage companies.

Leave a Reply

Your email address will not be published. Required fields are marked *